Cargando…
Aripiprazole in the acute and maintenance phase of bipolar I disorder
Bipolar affective disorder is a disabling illness with substantial morbidity and many management challenges. Traditional mood stabilizers such as lithium, valproate, and carbamazepine are often inadequate in controlling symptoms both during the acute and maintenance phase of treatment. Aripiprazole...
Autores principales: | Zupancic, Melanie, Gonzalez, Misty L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269345/ https://www.ncbi.nlm.nih.gov/pubmed/22298948 http://dx.doi.org/10.2147/TCRM.S22579 |
Ejemplares similares
-
Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence
por: McIntyre, Roger S, et al.
Publicado: (2011) -
Spotlight on once-monthly long-acting injectable aripiprazole and its potential as maintenance treatment for bipolar I disorder in adult patients
por: Torres-Llenza, Vanessa, et al.
Publicado: (2018) -
Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole
por: Muzina, David J
Publicado: (2009) -
Profile of aripiprazole in the treatment of bipolar disorder in children and adolescents
por: Kirino, Eiji
Publicado: (2014) -
Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study
por: Calabrese, Joseph R., et al.
Publicado: (2018)